Lars Gredsted
Lars is Senior Principal at Lundbeckfonden BioCapital. He has more than 15 years of experience in the life-science industry from management consulting, biotech, life-science investments, and pharma.
Before joining Lundbeckfonden BioCapital, Lars worked in business development at MedImmune / AstraZeneca in Cambridge UK. He was responsible for establishing research and development collaborations and licenses within oncology technology platforms. Prior to that, he worked with charitable life-science investments at the Wellcome Trust in London, business development in the biotech industry in Oxford, and a BCG consultant in Copenhagen. He has previously been a board member of Acesion Pharma in Copenhagen and Canbex Therapeutics in London.
Lars holds a master's degree in biochemistry from the University of Copenhagen, a PhD. from Heidelberg University and EMBL in Heidelberg, and has a business master's, MPhil, from Cambridge University.
Board Representative: Akamis Bio, Dania Therapeutics, Enterome, VarmX
